Clinical Testing | India Pharma Industry

Natco to Sell Rare Spinal Disease Drug Risdiplam for Rs 15,900 Each

Natco Pharma announced that its generic Risdiplam will launch at Rs 15,900 per bottle, which might be a transformative moment for treating rare diseases in India. Roche's Evrysdi, marketed for spinal muscular atrophy (SMA) treatment, reaches Rs. 6.2

Novo Nordisk Eyes Indian Market for Weight-Loss Drug Wegovy Launch

In a rapidly evolving Indian Pharmaceutical market, the growing demand for Obesity and diabetes drugs market is witnessing a huge heap through the continuous innovations by the leading companies. Notably, Danish pharm firm Novo Nordisk has announced

Gujarat FDCA Enhances Drug QC with 25 Advanced Spectrophotometers

In a significant initiative for drug safety and regulatory efficiency, the Gujarat Food and Drug Control Administration (FDCA) will procure...

Akums Unveils Ripasudil Timolol Combo for Glaucoma and Hypertension Care

Akums Drugs & Pharmaceuticals Ltd., India's leading contract development and manufacturing organization (CDMO), has announced the launch of a pioneering Ripasudil-Timolol combination therapy for glaucoma treatment.

Anteris Technologies treats 100+ patients with DurAVR THV for aortic stenosis

Multinational company Anteris Technologies Global Corp, is a head in Structural heart solutions, and it has reached an essential achievement with its DurAVR Transcatheter Heart valve(THV). Over 100 patients suffering from severe aortic stenosis

SPARC seeks US FDA approval for Phase 1 trial of SBO-154 in solid tumors

Sun Pharma Advanced Research business Ltd (SPARC), a biopharmaceutical business in the clinical stage, said that it has submitted an Investigational New Drug (IND) application to the FDA in the United States.

India's first MRI scanner to be tested at AIIMS, may cut costs by 50%

By introducing the indigenous MRI machine, a quantum leap has now been initiated for India in the fields of healthcare and medical technology. The Made-in-India MRI scanner is set to be installed by...

Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management?

In an interaction with India Pharma Outlook, Arushi Jain, Director at Akums Drugs & Pharmaceuticals Limited, discussed India’s growing nutraceutical sector, driven by rising health awareness and chronic diseases. She highlighted its integration with

Zydus Lifesciences Secures USFDA Approval for Generic Prostate Cancer Drug

Zydus Lifesciences Limited has established itself as a strong player in the world oncology market with its recent FDA approval to manufacture and sell a generic version of Apalutamide 60 mg tablets for the treatment of prostate cancer. The drug will

Surge in CKD Cases Sparks Call for Early Diagnosis and Better Care

Chronic Kidney Disease (CKD) is a growing public health crisis in India, affecting a significant percentage of the population and causing over 100,000 new cases of kidney failure annually. Despite its prevalence, early detection remains low, often le